Role of MIBI breast scintigraphy in evaluation of palpable breast lesions.
The sensitivity and specificity of MIBI breast scintigraphy, conventional mammography and ultrasound in differentiating malignant and benign palpable breast lesions was compared in 48 women. MIBI breast scintigraphy had a sensitivity of 97% a specificity of 69%, a positive predictive value of 87.5% and a negative predictive value of 91.7%. Ultrasound and mammography had comparable results with accuracy rates of approximately 93%. We conclude that MIBI breast scintigraphy may have a complementary role in the evaluation of palpable breast lesions, but is not specific enough to replace current imaging modalities.
Lam
W W
WW
Department of Diagnostic Radiology, Prince of Wales Hospital, Ngan Shing Street, Shatin, Hong Kong.
Yang
W T
WT
Chan
Y L
YL
Stewart
I E
IE
King
W
W
Metreweli
C
C
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001943:Breast Neoplasms / Q000000981:diagnostic imaging*; D002277:Carcinoma / Q000000981:diagnostic imaging*; D003287:Contrast Media; D005260:Female; D018226:Fibroadenoma / Q000000981:diagnostic imaging*; D006801:Humans; D008327:Mammography; D008875:Middle Aged; D003557:Phyllodes Tumor / Q000000981:diagnostic imaging*; D011446:Prospective Studies; D011877:Radionuclide Imaging; D012680:Sensitivity and Specificity; D017256:Technetium Tc 99m Sestamibi; D016217:Ultrasonography, Mammary
D003287:Contrast Media; D017256:Technetium Tc 99m Sestamibi